Spanish researchers find a new promising therapeutic target for glioblastoma

Google+ Pinterest LinkedIn Tumblr +

Glioblastoma is the most aggressive brain cancer due to its ability to escape the immune system.

However, the way in which this tumour manages to induce this immune tolerance was not known in detail.

Research published in PNAS carried out at the Instituto de Neurociencias UMH-CSIC, in Alicante (Spain), and the IMIB-Arrixaca in Murcia (Spain), has find out in detail how this tumour invades healthy tissue with hardly any resistance, a finding that could become glioblastoma´s Achilles heel.

The team led by Dr. Salvador Martínez, director of the UMH-CSIC Institute of Neurosciences in Alicante (Spain), and Dr. Rut Valdor, of IMIB-Arrixaca in Murcia (Spain), has shown how glioblastoma hijacks the contractile cells that surround the blood vessels of the brain and are also part of the barrier that protects it.

The objective is to deactivate the anti-tumoural function of that these cells, called pericytes, and force them to work on the expansion of the tumour.

This change in the function of the pericytes, which are no longer defending cells to become “enemies”, is achieved by glioblastoma by altering one of the cellular “cleaning services”: chaperone mediated autophagy.

Through autophagy the cell breaks down and destroys damaged or abnormal proteins.

And chaperones are proteins that actively work on this task.

The alteration by the glioblastoma of this cleaning service changes the proinflammatory defense function of the pericytes by another immunosuppressive, which favours the survival of the tumour.

Researchers have been able to verify in a mouse model that blocking this anomalous autophagy hinders the development of the tumour, causing defective adhesion of glioblastoma to the pericyte and, with it, the death of cancer cells, so it becomes a promising therapeutic goal.

“This work reveals a previously unknown capacity of glioblastoma to modulate chaperone mediated autophagy (AMC) in pericytes, and thus promote tumour progression. Our results point to the AMC as a promising therapeutic goal to treat this aggressive brain cancer so far without cure”, says Dr. Martínez.

Previous this group showed that the influence of glioblastoma on the pericyte prevents destructive T lymphocytes from attacking the tumour.

“That is why the brain does not detect glioblastoma and cannot react against it,” explains Salvador Martínez, director of the Experimental Neurobiology group at the Instituto of Neurociencias UMH-CSIC in Alicante.

This new finding narrows the fence against this aggressive brain tumour and is in line with the current hypothesis about the role of autophagy in suppressing the early stages of tumour development and how alterations in this process contribute to its progression.

Glioblastoma multiforme is a highly invasive cancer that is characterised by changes in cerebral blood vessels and the gradual invasion of surrounding tissues.

It is the most frequent brain tumour with the worst prognosis.

Despite decades of intense research, its complex biology is still not fully understood and existing treatments have not achieved a significant increase in survival.


Source: Spanish National Research Council (CSIC) 

Share.

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.